These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 16828635
1. Trends and outcomes associated with angiotensin-converting enzyme inhibitors. Doubeni C, Bigelow C, Lessard D, Spencer F, Yarzebski J, Gore J, Gurwitz J, Goldberg R. Am J Med; 2006 Jul; 119(7):616.e9-16. PubMed ID: 16828635 [Abstract] [Full Text] [Related]
2. Communitywide trends in the use and outcomes associated with beta-blockers in patients with acute myocardial infarction: the Worcester Heart Attack Study. Silvet H, Spencer F, Yarzebski J, Lessard D, Gore JM, Goldberg RJ. Arch Intern Med; 2003 Oct 13; 163(18):2175-83. PubMed ID: 14557215 [Abstract] [Full Text] [Related]
3. Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting. Spencer FA, Lessard D, Doubeni C, Yarzebski J, Gore JM, Goldberg RJ. Am Heart J; 2007 Jan 13; 153(1):140-6. PubMed ID: 17174652 [Abstract] [Full Text] [Related]
4. Age-related trends (1986-1993) in the use of thrombolytic agents in patients with acute myocardial infarction. The Worcester Heart Attack Study. Chandra H, Yarzebski J, Goldberg RJ, Savageau J, Singleton C, Gurwitz JH, Gore JM. Arch Intern Med; 1997 Apr 14; 157(7):741-6. PubMed ID: 9125005 [Abstract] [Full Text] [Related]
5. Decade-long trends (1986 to 1997) in the medical treatment of patients with acute myocardial infarction: A community-wide perspective. Spencer F, Scleparis G, Goldberg RJ, Yarzebski J, Lessard D, Gore JM. Am Heart J; 2001 Oct 14; 142(4):594-603. PubMed ID: 11579348 [Abstract] [Full Text] [Related]
6. Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction. Milonas C, Jernberg T, Lindbäck J, Agewall S, Wallentin L, Stenestrand U, RIKS-HIA Group. Am J Cardiol; 2010 May 01; 105(9):1229-34. PubMed ID: 20403471 [Abstract] [Full Text] [Related]
7. Long-term trends of angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker use after heart failure hospitalization in community-dwelling seniors. Setoguchi S, Levin R, Winkelmayer WC. Int J Cardiol; 2008 Apr 10; 125(2):172-7. PubMed ID: 17997175 [Abstract] [Full Text] [Related]
8. A 25-year perspective into the changing landscape of patients hospitalized with acute myocardial infarction (the Worcester Heart Attack Study). Goldberg RJ, Spencer FA, Yarzebski J, Lessard D, Gore JM, Alpert JS, Dalen JE. Am J Cardiol; 2004 Dec 01; 94(11):1373-8. PubMed ID: 15566906 [Abstract] [Full Text] [Related]
9. Effect of age on the use of evidence-based therapies for acute myocardial infarction. Tran CT, Laupacis A, Mamdani MM, Tu JV. Am Heart J; 2004 Nov 01; 148(5):834-41. PubMed ID: 15523314 [Abstract] [Full Text] [Related]
10. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age. Setoguchi S, Glynn RJ, Avorn J, Levin R, Winkelmayer WC. Am J Cardiol; 2007 Oct 01; 100(7):1061-7. PubMed ID: 17884362 [Abstract] [Full Text] [Related]
11. Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century: a multinational perspective. Goldberg RJ, Spencer FA, Steg PG, Flather M, Montalescot G, Gurfinkel EP, Kennelly BM, Goodman SG, Dedrick R, Gore JM, Global Registry of Acute Coronary Events Investigators. Arch Intern Med; 2007 Sep 10; 167(16):1766-73. PubMed ID: 17846396 [Abstract] [Full Text] [Related]
12. Changes over time in the incidence and case-fatality rates of primary ventricular fibrillation complicating acute myocardial infarction: perspectives from the Worcester Heart Attack Study. Thompson CA, Yarzebski J, Goldberg RJ, Lessard D, Gore JM, Dalen JE. Am Heart J; 2000 Jun 10; 139(6):1014-21. PubMed ID: 10827382 [Abstract] [Full Text] [Related]
13. Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge. Butler J, Arbogast PG, Daugherty J, Jain MK, Ray WA, Griffin MR. J Am Coll Cardiol; 2004 Jun 02; 43(11):2036-43. PubMed ID: 15172409 [Abstract] [Full Text] [Related]
14. Declining length of hospital stay for acute myocardial infarction and postdischarge outcomes: a community-wide perspective. Spencer FA, Lessard D, Gore JM, Yarzebski J, Goldberg RJ. Arch Intern Med; 2004 Apr 12; 164(7):733-40. PubMed ID: 15078642 [Abstract] [Full Text] [Related]
16. Decade-long changes in the use of combination evidence-based medical therapy at discharge for patients surviving acute myocardial infarction. Spencer FA, Lessard D, Yarzebski J, Gore JM, Goldberg RJ. Am Heart J; 2005 Oct 12; 150(4):838-44. PubMed ID: 16209991 [Abstract] [Full Text] [Related]